Sit Investment Associates’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-85,500
| Closed | -$608K | – | 538 |
|
|
2025
Q1 | $608K | Hold |
85,500
| – | – | 0.01% | 399 |
|
|
2024
Q4 | $997K | Buy |
85,500
+25,600
| +43% | +$299K | 0.02% | 380 |
|
|
2024
Q3 | $1.23M | Hold |
59,900
| – | – | 0.03% | 363 |
|
|
2024
Q2 | $1.34M | Buy |
59,900
+22,350
| +60% | +$500K | 0.03% | 340 |
|
|
2024
Q1 | $1.03M | Buy |
37,550
+3,100
| +9% | +$85.3K | 0.02% | 357 |
|
|
2023
Q4 | $1.05M | Hold |
34,450
| – | – | 0.03% | 354 |
|
|
2023
Q3 | $1.09M | Hold |
34,450
| – | – | 0.03% | 335 |
|
|
2023
Q2 | $1.41M | Buy |
34,450
+9,775
| +40% | +$399K | 0.04% | 326 |
|
|
2023
Q1 | $920K | Buy |
+24,675
| New | +$920K | 0.03% | 358 |
|